Myasthenia gravis and autoimmunity.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology*; D002800:Cholinesterase Inhibitors; D004593:Electrophorus; D000939:Epitopes; D006168:Guinea Pigs; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000276:immunology* / Q000628:therapy; D009469:Neuromuscular Junction / Q000502:physiology; D011817:Rabbits; D051381:Rats; D011978:Receptors, Nicotinic / Q000276:immunology; D009435:Synaptic Transmission; D013934:Thymectomy; D013945:Thymoma / Q000276:immunology; D013952:Thymus Hyperplasia / Q000276:immunology; D013953:Thymus Neoplasms / Q000276:immunology
D002800:Cholinesterase Inhibitors; D000939:Epitopes; D007166:Immunosuppressive Agents; D011978:Receptors, Nicotinic; D000109:Acetylcholine